Wells Fargo & Company Agios Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 68,137 shares of AGIO stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,137
Previous 34,808
95.75%
Holding current value
$2.46 Million
Previous $1.14 Million
74.63%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$206 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$175 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$127 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$88.4 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.98B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...